Orchestra BioMed Holdings, Inc. (OBIO) insider trading

By person

12 insiders · 1 transaction

18.7×

David P. Hochman holds 18.7 times base salary in stock. $11.17M of shares against $595.00K in salary for 2025.

Salary from the company's own proxy. The shares are what David P. Hochman last reported holding, valued at $5.74, the price Common Stock, par value $0.0001 per share ("Common Stock") was last bought or sold at on the open market here, on 2 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Darren Sherman

See Remarks

—

$86.10K (1) scheduled

−$86.10K

1,106,402

1.84%

$6.35M

+44.5%

Rtw Investments, LP entity

10% owner

—

9,556,063

15.90%

$54.85M

+16.4%

Perceptive Advisors LLC entity

10% owner

—

5,292,556

8.81%

$30.38M

+15.2%

David P Hochman

See Remarks

—

1,945,718

3.24%

$11.17M

+46.0%

Andrew Lawrence Taylor

Chief Financial Officer

—

589,989

0.9816%

$3.39M

+55.9%

Jason Aryeh

Director

—

118,118

0.1965%

$678.00K

+72.8%

Eric S Fain

Director

—

107,130

0.1782%

$614.93K

+119.9%

John Prosper Mack

Director

—

66,544

0.1107%

$381.96K

+417.3%

Pamela Ann Connealy

Director

—

66,038

0.1099%

$379.06K

+210.2%

David Pacitti

Director

—

54,750

0.0911%

$314.27K

+212.0%

Chris Cleary

Director

—

29,153

0.0485%

$167.34K

—

Joshua Aiello

Principal Accounting Officer

—

18,441

0.0307%

$105.85K

+268.8%

Orchestra BioMed Holdings, Inc.

What the insiders did Scheduled selling only

By person